From: A nomogram to predict hyperkalemia in patients with hemodialysis: a retrospective cohort study
Variable | HK (n = 159) | Non-HK (n = 242) | P-value |
---|---|---|---|
Age, year | 61.86 ± 12.22 | 62.53 ± 15.43 | 0.631 |
Blood flow (mm/s) | 245.53 ± 27.80 | 238.80 ± 37.49 | 0.040 |
Height(cm) | 162.86 ± 8.13 | 162.39 ± 8.02 | 0.566 |
Pre-dialysis weight (kg) | 61.08 ± 11.52 | 58.85 ± 12.02 | 0.065 |
Hemoglobin(g/L) | 114.22 ± 20.31 | 104.85 ± 21.94 | 0.000 |
Serum sodium(mmol/L) | 137.43 ± 3.66 | 138.84 ± 3.49 | 0.000 |
Serum calcium(mmol/L) | 2.06 ± 0.46 | 2.14 ± 0.29 | 0.050 |
Albumin(g/L) | 37.72 ± 5.97 | 35.26 ± 5.40 | 0.000 |
TC(mmol/L) | 4.40 ± 1.27 | 4.31 ± 1.30 | 0.497 |
HDL(mmol/L) | 0.99 ± 0.34 | 0.95 ± 0.36 | 0.318 |
Hemodialysis duration (month) | 30 (11, 55) | 10 (5, 31.25) | <0.001 |
Number of hemodialysis sessions | 267 (104, 308) | 92 (17, 245.5) | <0.001 |
Ultrafiltration volume(L) | 3000 (2200, 3500) | 2300 (1600, 3000) | <0.001 |
CRP(mg/L) | 2.16 (1, 9.2) | 5 (2, 20.05) | 0.001 |
BUN (mmol/L) | 24.1 (17.2, 29.5) | 15.1 (9.18, 23.25) | <0.001 |
Uric acid(μmol/L) | 382 (295, 469) | 336.18 (185.75, 436.75) | 0.001 |
eGFR(ml/min) | 4.9 (3.9, 6.7) | 7.25 (4.80, 12.30) | <0.001 |
Glucose(mmol/L) | 5.87 (4.89, 8.16) | 5.37 (4.59, 7.41) | 0.031 |
Serum creatinine(μmol/L) | 778 (614, 953) | 581 (346, 804) | <0.001 |
Serum phosphate(mmol/L) | 1.78 (1.31, 2.18) | 1.37 (0.99, 1.79) | <0.001 |
TG(mmol/L) | 1.32 (0.92, 2.03) | 1.39 (0.96, 1.93) | 0.985 |
LDL(mmol/L) | 2.02 (1.48, 2.62) | 2.03 (1.58, 2.56) | 0.962 |
PTH(pg/ml) | 238 (139.4, 445.6) | 213.4 (82.33, 384.45) | 0.020 |
Gender | 0.292 | ||
Male | 90 (56.6%) | 151 (62.4%) | |
Female | 69 (43.4%) | 91 (37.6%) | |
Primary disease | 0.309 | ||
Primary nephropathy | 59 (37.11%) | 107 (44.2%) | |
Glomerulonephritis | 33 (20.75%) | 51 (21.07%) | |
IgA nephropathy | 20 (12.58%) | 45 (18.59%) | |
Membranous nephropathy | 5 (3.14%) | 8 (3.31%) | |
Interstitial nephritis | 1 (0.63%) | 3 (1.24%) | |
Secondary nephropathy | 79 (49.69%) | 98 (40.5%) | |
Diabetes nephropathy | 37 (23.27%) | 43 (17.77%) | |
Hypertensive nephropathy | 42 (26.42%) | 55 (22.73%) | |
Hereditary nephropathy | 3 (1.9%) | 10 (4.1%) | |
Unknown etiology | 18 (11.32%) | 27 (11.16%) | |
Professional | 0.693 | ||
Farmer | 126 (79.7%) | 189 (78.1%) | |
Worker | 4 (2.5%) | 8 (3.3%) | |
Clerk | 8 (5.1%) | 7 (2.9%) | |
Retirees | 7 (4.4%) | 19 (7.9%) | |
Student | 0 (0.0%) | 1 (0.4%) | |
Self-employed | 8 (5.1%) | 11 (4.5%) | |
Unemployed people | 5 (3.2%) | 7 (2.9%) | |
Education level | 0.501 | ||
Primary school diploma | 32 (20.3%) | 63 (26.0%) | |
Junior high school diploma | 26 (16.5%) | 43 (17.8%) | |
High school diploma | 8 (5.1%) | 15 (6.2%) | |
College diploma | 6 (3.8%) | 11 (4.5%) | |
Illiteracy | 86 (54.4%) | 110 (45.5%) | |
Hemodialysis vascular access | 0.007 | ||
Temporary tube | 5 (3.1%) | 15 (6.2%) | |
Long term tube | 36 (22.6%) | 84 (34.7%) | |
Fistula | 118 (74.2%) | 143 (59.1%) | |
Dialysis modalities | 0.300 | ||
HD | 26 (16.4%) | 51 (21.1%) | |
HD + HF | 133 (83.6%) | 191 (78.9%) | |
Furosemide use | 0.076 | ||
Yes | 118 (74.2%) | 158 (65.3%) | |
No | 41 (25.8%) | 84 (34.7%) | |
ACEI/ARB | 0.342 | ||
Yes | 103 (64.8%) | 169 (69.8%) | |
No | 56 (35.2%) | 73 (30.2%) | |
Hypertension | 0.391 | ||
Yes | 39 (24.5%) | 50 (20.7%) | |
No | 120 (75.5%) | 192 (79.3%) | |
Diabetes mellitus | 0.040 | ||
Yes | 86 (54.1%) | 157 (64.9%) | |
No | 73 (45.9%) | 85 (35.1%) |